Investing Ideas
/
U.S. Pharmaceuticals & Biotech Sustainable Track Record

U.S. Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

7 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MEDP Medpace Holdings	US$333.34	-1.7%	8.7%	US$10.6b	US$347.92	PE28.3x	E10.8%	n/a
CPRX Catalyst Pharmaceuticals	US$21.07	-2.5%	25.3%	US$2.6b	US$32.25	PE17.6x	E17.5%	n/a
HALO Halozyme Therapeutics	US$47.99	1.8%	29.8%	US$6.1b	US$64.13	PE15.6x	E21.1%	n/a
PBYI Puma Biotechnology	US$3.13	11.4%	-27.7%	US$151.2m	US$4.33	PE6.6x	E-45.4%	n/a
ETST Earth Science Tech	US$0.12	15.0%	65.0%	US$39.0m	n/a	PE14.9x	n/a	n/a
MDXG MiMedx Group	US$9.48	2.3%	8.1%	US$1.4b	US$13.40	PE17.5x	E-1.9%	n/a
AMPH Amphastar Pharmaceuticals	US$36.84	-5.8%	-40.4%	US$1.8b	US$58.20	PE11.2x	E6.7%	n/a

Page 1 of 1